Dose-dependent relationship between acidosis at birth and likelihood of death or cerebral palsy

Rod Kelly1,2, S M Ramaiah3, Helen Sheridan4

  • 1Scottish Specialist Transport and Retrieval Service, Royal Infirmary of Edinburgh, Edinburgh, UK.

Insights

Severe acidosis in newborns, indicated by low pH or high base deficit within an hour of birth, is linked to increased risks of poor outcomes. This study confirms a dose-dependent relationship between acidosis severity and adverse neonatal and neurodevelopmental results.

Area of Science:

  • Neonatalogy
  • Perinatal Medicine
  • Pediatric Neurology

Background:

  • Infant acid-base status at birth offers insights into neonatal condition.
  • Umbilical cord blood pH <7.0 or base deficit ≥12 mmol/L indicates increased adverse outcome risk.
  • Prognostic value of acidosis degree needs clarification due to varied study parameters.

Purpose of the Study:

  • To investigate the relationship between the degree of acidosis at birth and neonatal/neurodevelopmental outcomes.
  • To clarify the prognostic value of acidosis severity in infants born at ≥35 weeks gestation.
  • To establish dose-dependent relationships between acidosis markers and adverse outcomes.

Main Methods:

  • Retrospective review of clinical data for infants born ≥35 weeks gestation (2005-2013).
  • Inclusion criteria: lowest recorded pH <7 or highest base deficit ≥12 mmol/L (cord or neonatal blood gas within 1 hour).
  • Neurodevelopmental outcomes for infants with encephalopathy were collected from follow-up data.

Main Results:

  • 506 out of 56,574 infants met inclusion criteria (0.9%).
  • Adverse outcomes increased with worsening acidosis: combined death/cerebral palsy rates were 3%, 10%, 40% for pH 6.9-6.99, 6.8-6.89, <6.8.
  • Rates were 8%, 14%, 59% for base deficit 12-15.9, 16-19.9, ≥20 mmol/L, respectively.

Conclusions:

  • A dose-dependent relationship exists between acidosis degree within one hour of delivery and adverse outcomes.
  • Worsening acidosis correlates with higher likelihood of adverse neonatal and neurodevelopmental outcomes.
  • Findings support the prognostic significance of acidosis severity in term and preterm infants.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
323
Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and...
1.3K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
335
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
256
Disorders of Acid-Base Balance01:29

Disorders of Acid-Base Balance

The human body maintains a precise pH range of arterial blood between 7.35 and 7.45. Deviations result in either acidosis (pH < 7.35) or alkalosis (pH > 7.45). These conditions are further classified as respiratory or metabolic disorders based on their underlying cause.
Respiratory Acidosis and Alkalosis
Respiratory acidosis occurs due to an increase in the partial pressure of carbon dioxide PCO2 in the blood. It often arises from shallow breathing or impaired gas exchange caused by...
2.2K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.3K